| Target Price | $9.22 |
| Price | $17.95 |
| Deviation |
48.64%
register free of charge
|
| Number of Estimates | 7 |
|
7 Analysts have issued a price target BBVA Banco Frances S.A. - ADR 2027 .
The average BBVA Banco Frances S.A. - ADR target price is $9.22.
This is
48.64%
register free of charge
$10.75
40.14%
register free of charge
$6.86
61.78%
register free of charge
|
|
| A rating was issued by 12 analysts: 11 Analysts recommend BBVA Banco Frances S.A. - ADR to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the BBVA Banco Frances S.A. - ADR stock has an average upside potential 2027 of
48.64%
register free of charge
|
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 1.75 | 2.42 |
| 101.55% | 37.85% | |
| Net Margin | 13.64% | -1.10% |
| 6.52% | 108.06% |
4 Analysts have issued a sales forecast BBVA Banco Frances S.A. - ADR 2025 . The average BBVA Banco Frances S.A. - ADR sales estimate is
This results in the following potential growth metrics:
4 BBVA Banco Frances S.A. - ADR Analysts have issued a net profit forecast 2025. The average BBVA Banco Frances S.A. - ADR net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 0.39 | -0.04 |
| 116.67% | 110.26% | |
| P/E | negative | |
| EV/Sales | 1.71 |
4 Analysts have issued a BBVA Banco Frances S.A. - ADR forecast for earnings per share. The average BBVA Banco Frances S.A. - ADR EPS is
This results in the following potential growth metrics and future valuations:
BBVA Banco Frances S.A. - ADR...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


